Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03278353 · ClinicalTrials.gov registry record · NA

Fulfillment of Expectations for Patients With FAI Syndrome

A NA study, sponsored by Duke University.

Terminated
Registry status
NA
Development phase
6
Enrollment target

NCT03278353: Clinical Trial NA study, sponsored by Duke University.

NCT03278353 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03278353, a NA study, was terminated before completion, sponsored by Duke University.

TERMINATED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

A total of 63 participants will be recruited through 3 local surgeons in Durham, North Carolina after distinctive differential diagnostic methods, all with extensive expertise in intra-articular hip pathology and arthroscopy. The surgeons will offer the opportunity to participate in the trial by providing information to the recipient. Potential participants that do not contact project team members will be contacted by phone if they do not respond to the initial invitation. Potential participants will be initially screened by telephone interview, followed by a clinical examination to confirm study eligibility. The blinded researchers will obtain informed consent and will perform outcome assessments Purpose of the Study: 1) measure the mediating effect of baseline patient expectations on fulfillment of expectations (for both conservative care and surgery, measured at 6 weeks and at 1 year respectively) in a cohort of patients with a diagnosis of FAI Syndrome who receive six weeks of conservative physical therapy intervention and 2) measure the effect of baseline expectations on patient reported outcomes (e.g., HAGOS, pain, global rating of change) at six weeks.

Primary Outcome

fulfillment of expectations after conservative care implemented as by outcome questionnaire 'Fulfillment of expectations'

Interventions

  • OTHER Exercise
  • OTHER Manual Therapy

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2017-11-07
Est. Completion 2018-07-31
Phase NA
Duke University

1,725 total trials

Why NCT03278353 stopped before completion

NCT03278353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Exercise is the first listed.

NCT03278353 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03278353 about?

NCT03278353 is a clinical study titled "Fulfillment of Expectations for Patients With FAI Syndrome". A total of 63 participants will be recruited through 3 local surgeons in Durham, North Carolina after distinctive differential diagnostic methods, all with extensive expertise in intra-articular hip pathology and arthroscopy. The surgeons will offer the opportunity to participate in the trial by pro...

What is the current status of trial NCT03278353?

This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2017-11-07. Estimated completion is 2018-07-31.

What interventions are being tested in trial NCT03278353?

The interventions under investigation include: Exercise (OTHER), Manual Therapy (OTHER).

Who is sponsoring clinical trial NCT03278353?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03278353's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03278353, the US trial registry maintained by the National Library of Medicine. NCT03278353 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.